Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by Vinny57on May 27, 2020 1:15am
161 Views
Post# 31076459

RE:Pablo

RE:PabloAnybody doing any digging will find this Zuanic guy has a pretty good track record. It is always in your best interest to investigate these 'so called' analysts yourself. Good call PC. 
It would be nice to be sitting in the $6 - $8 range before the small 'boom' that we will hear at the end of July.  A 20% - 30% increase at that time is reasonable, but better yet ....... ( I expect the howitzers are getting ready for this halloween ).

ProfCornelius wrote: This is Pablo's call..for now anyway!

Ratings And Price Targets

Cantor analyst Pablo Zuanic maintained the following ratings and price targets on cannabis stocks:

Overweight

  • Aurora Cannabis Inc. (NYSE: ACB) with a CA$27 price target. 
  • Aphria Inc. (NYSE: APHA) with a CA$9.55 price target. 
So that would give ACB an MC of 2.97B at a price target of $27CDN!

APHRIA, on the other hand, would have a MC of 2.73B at a price target of $9.55CDN! Based on 286M shares not 267M shares O/S.

Aphria will be upgraded much further from here over the next twelve months but I'm sure you see my point....these analysts and the street are both in for a few eye openers this year from Aphria and I cannot wait!

Also, a little bird told me a few nights ago about a new REC 2.0 product that Aphria will be rolling out soon...#bigseller #waitandseeapproachisworking

Prof







<< Previous
Bullboard Posts
Next >>